The US FDA has cleared an investigational new drug (IND) application for HG202, by HuidaGene Therapeutics. This drug is the ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

Patient advocates are hoping for change under new director Michelle Tarver, while industry groups hope she will build on ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss significant developments involving cannabis in ...

The FDA has its own expertise, but as an executive branch ... As to changes he’d like to see in the biopharma industry, ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

One of the most remarkable aspects of the populist alliance between Robert F. Kennedy Jr. and Donald Trump is that it puts ...

Trump also endorsed medical research and financial services, two components of the marijuana industry that are stymied by its ...